NCT00775996View on ClinicalTrials.gov

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

Clorazepate Dipotassium 15mg Tablets

Trial Locations (1)

68502

MDS Pharma Services, Lincoln

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00775996 - Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter